US FDA Shows Support For Generic Drug User Fee Goals Amid Cutbacks

 
• By Michael McCaughan
  
Arrows hitting targets
The FDA's Office of Generic Drugs understands the importance of hitting user fee goal dates. (Shutterstock)

More from Generics

More from Biosimilars & Generics